ClinicalTrials.Veeva

Menu

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

I

Institut de Cancérologie de Lorraine

Status

Completed

Conditions

Brain Metastasis

Treatments

Radiation: whole brain radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT02913534
ICL_2014_0001

Details and patient eligibility

About

The aim is to identify in patients with brain metastases the predictive factors of overall survival, survival without local recurrence and survival with progression-free brain metastases after complementary whole brain radiotherapy.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with one to three brain metastases treated in our department with hypofractionated stereotactic radiotherapy (SRT) from March 2008 to February 2013.

Exclusion criteria

  • A patient record captured after February 2013.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems